Regeneron Pharmaceuticals Inc said on Tuesday the U.S. government signed a $450 million contract with the drugmaker to make and supply its potential double antibody cocktail for COVID-19.
FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus linked to COVID-19, better known as the coronavirus linked to the Wuhan outbreak, shared with Reuters on February 18, 2020. NEXU Science Communication/via REUTERS
The cocktail, REGN-COV2, is in separate clinical trials assessing its effectiveness in preventing and treating COVID-19, the company saidRegeneron signed the contract with the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority and the Department of Defense. The doses manufactured under the project will be owned by the federal government.
The government will support manufacturing REGN-COV2 for immediate use in the country, if the clinical trials are successful and the U.S. Food and Drug Administration grants emergency use authorization or product approval. It expects a range of 70,000 to 300,000 potential treatment doses or 420,000 to 1,300,000 prevention doses to be available from these lots, with initial doses to be ready as early as end of summer.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Operation Warp Speed commits $1.6 billion to Covid-19 vaccine maker Novavax'Operation Warp Speed,' the federal government's Covid-19 vaccine program, has announced the largest government Covid-19 vaccine contract to date — a $1.6 billion contract with Novavax, a Maryland biotech company.
Read more »
Coronavirus tally: Global COVID-19 cases rise to 11.5 million, U.S. to nearly 2.9 millionThe global tally for confirmed cases of the coronavirus that causes COVID-19 climbed to 11.47 million on Monday, according to data aggregated by Johns Hopkins University, with the U.S. leading the way by far with 2.89 million cases. The number of deaths grew to 534,784, while the number of people who have recovered reached 6.19 million. The U.S. death toll is 129,947, while 906,763 have recovered. Within the U.S., infections have climbed in 38 states over the past 14 days, according to a New York Times tracker, with Idaho, Montana and Florida leading the way. Internationally, Brazil is second to the U.S. with 1.60 million cases and 64,867 deaths, but is first with 1.03 million recovered. India is third measured by cases at 697,413, followed by Russia with 686,777 and Peru with 302,718. The U.K. has 44,305 fatalities, the highest in Europe and third highest in the world. China, where the illness was first reported late last year, has 84,871 cases and 4,641 fatalities.
Read more »
Regeneron begins coronavirus antibody cocktail late-stage trialRegeneron Pharmaceuticals said on Monday it began late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating Covid-19.
Read more »
Regeneron Advances Covid-19 Drug Into Later-Stage TestingRegeneron Pharmaceuticals said it is starting later-stage studies of its experimental Covid-19 drug, a quick move into testing that could establish whether it can be used for treatment and prevention
Read more »
Hundreds of millions of dollars goes to COVID-19 contractors accused of prior fraudExperts say COVID-19 contracts will cost taxpayers far more money in the long-run because fraud is not being weeded out of the system upfront.
Read more »